Loading...
Market
Will Ozempic show a 70% reduction in dementia risk by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Final study results published by credible scientific journals or announced by the research institutions involved
Story
Ozempic Shows Promise in Reducing Advanced Alzheimer's Risk, Potential 70% Reduction in Dementia by 2025
Dec 26, 2024, 08:53 AM
Recent studies are exploring the potential of Ozempic, a weight-loss medication, to aid in the fight against advanced Alzheimer's disease. Scientists are investigating its anti-inflammatory properties, which may contribute to a significant reduction in the risk of developing dementia. Early findings indicate that patients receiving the medication could see up to a 70% reduced risk of dementia. However, further research is needed, with more comprehensive results expected in 2025.
View original story
Similar markets
No action taken • 25%
Product recall • 25%
Other regulatory actions • 25%
Safety label update • 25%
No significant risk found • 25%
Confirms significant risk • 25%
Study retracted • 25%
Inconclusive results • 25%
No decision made • 25%
No distribution approved • 25%
Approve distribution city-wide • 25%
Approve limited distribution • 25%
By Novo Nordisk • 25%
By health organizations • 25%
By both • 25%
No campaigns • 25%
No publication • 25%
Confirms link • 25%
Refutes link • 25%
Inconclusive • 25%
Stroke • 25%
Heart Disease • 25%
Chronic Kidney Disease • 25%
Other • 25%